The 4 analysts offering 12-month price forecasts for LogicBio Therapeutics Inc have a median target of 22.00, with a high estimate of 26.00 and a low estimate of 18.00. The median estimate represents a +134.54% increase from the last price of 9.38.
The current consensus among 5 polled investment analysts is to Buy stock in LogicBio Therapeutics Inc. This rating has held steady since August, when it was unchanged from a Buy rating.Move your mouse over past months for detail
Earnings and Sales Forecasts
Earnings per Share -$0.49
Reporting Date Apr 06
Earnings per Share
Move your mouse over a quarter or year to see how estimates have changed over time.